Clinical Trials Directory

Trials / Completed

CompletedNCT00721994

Post-PMA Approval Study: 10 Year Follow-Up IDE Subjects

Cormet Resurfacing Hip System Post PMA Approval Study (PMA #P050016)Pre-market (IDE) Study Group 10 Year Follow-Up With Metal Ion and Renal Function Data Collection Clinical Investigation Plan

Status
Completed
Phase
Study type
Observational
Enrollment
231 (actual)
Sponsor
Corin · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

primary endpoint of this Study is maintenance of "at least good clinical status" for a period of 10 years following initial implantation among Cormet procedures enrolled inthe pre-market IDE.

Detailed description

Maintaining "at least good clinical status" will be determined based upon the composite clinical success (CCS) criterion which includes no revision, removal, or replacement of any device component and a Harris Hip Total score of greater or equal to 80 points.

Conditions

Interventions

TypeNameDescription
DEVICECormet Hip Resurfacing SystemCormet Hip Resurfacing System

Timeline

Start date
2008-05-01
Primary completion
2017-06-01
Completion
2017-08-01
First posted
2008-07-25
Last updated
2018-11-21

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00721994. Inclusion in this directory is not an endorsement.

Post-PMA Approval Study: 10 Year Follow-Up IDE Subjects (NCT00721994) · Clinical Trials Directory